Menu

UAE Blogger

Blog posts February 2020

Takeda Receives Positive CHMP Opinion for Subcutaneous Formulation of Vedolizumab for use as Maintenance Therapy in Adults with Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease

− If approved, the additional treatment modality will provide more options for how patients in Europe receive the gut-selective biologic vedolizumab

− Recommendation brings vedolizumab one step closer to becoming the only maintenance therapy with both intravenous and subcutaneous formulation op…

Read more

 Posted in General
1 blog post

Blog Sear

BlogC Archive

Comments

There are currently no blog comments.